This is a preprint.
The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET (REFINE PET): Rationale and Design
- PMID: 40672503
- PMCID: PMC12265749
- DOI: 10.1101/2025.07.10.25330435
The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET (REFINE PET): Rationale and Design
Update in
-
The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET(REFINE PET): Rationale and Design.J Nucl Cardiol. 2025 Aug 5:102449. doi: 10.1016/j.nuclcard.2025.102449. Online ahead of print. J Nucl Cardiol. 2025. PMID: 40774620
Abstract
Rationale: The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET (REFINE PET) was established to aggregate PET and associated computed tomography (CT) images with clinical data from hospitals around the world into one comprehensive research resource.
Methods: REFINE PET is a multicenter, international registry that contains both clinical and imaging data. The PET scans were processed using QPET software (Cedars-Sinai Medical Center, Los Angeles, CA), while the CT scans were processed using deep learning (DL) to detect coronary artery calcium (CAC). Patients were followed up for the occurrence of major adverse cardiovascular events (MACE), which include death, myocardial infarction, unstable angina, and late revascularization (>90 days from PET).
Results: The REFINE PET registry currently contains data for 35,588 patients from 14 sites, with additional patient data and sites anticipated. Comprehensive clinical data (including demographics, medical history, and stress test results) were integrated with more than 2200 imaging variables across 42 categories. The registry is poised to address a broad range of clinical questions, supported by correlating invasive angiography (within 6 months of MPI) in 5972 patients and a total of 9252 major adverse cardiovascular events during a median follow-up of 4.2 years.
Conclusion: The REFINE PET registry leverages the integration of clinical, multimodality imaging, and novel quantitative and AI tools to advance the role of PET/CT MPI in diagnosis and risk stratification.
Keywords: PET; artificial intelligence; coronary artery disease; myocardial perfusion imaging; quantitative analysis.
Figures


Similar articles
-
The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET(REFINE PET): Rationale and Design.J Nucl Cardiol. 2025 Aug 5:102449. doi: 10.1016/j.nuclcard.2025.102449. Online ahead of print. J Nucl Cardiol. 2025. PMID: 40774620
-
Multicenter Evaluation of Myocardial Flow Reserve as a Prognostic Marker for Mortality in 13N-Ammonia PET Myocardial Perfusion Imaging.medRxiv [Preprint]. 2025 Jun 25:2025.06.24.25330229. doi: 10.1101/2025.06.24.25330229. medRxiv. 2025. PMID: 40585149 Free PMC article. Preprint.
-
Interaction of AI-Enabled Quantitative Coronary Plaque Volumes on Coronary CT Angiography, FFRCT, and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry.Circ Cardiovasc Imaging. 2024 Mar;17(3):e016143. doi: 10.1161/CIRCIMAGING.123.016143. Epub 2024 Mar 12. Circ Cardiovasc Imaging. 2024. PMID: 38469689
-
Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction.Health Technol Assess. 2004 Jul;8(30):iii-iv, 1-207. doi: 10.3310/hta8300. Health Technol Assess. 2004. PMID: 15248938
-
Artificial intelligence for diagnosing exudative age-related macular degeneration.Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2. Cochrane Database Syst Rev. 2024. PMID: 39417312
References
-
- Association A.H., Cardiovascular Disease: A Costly Burden for America Projections Through 2035. 2017.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources